Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series
Metadatos
Mostrar el registro completo del ítemAutor
Urias-Barreras, Cynthia M.; Rodríguez Archilla, Alberto; Canizalez-Roman, Adrian; Bastidas, Daniela A.; León-Sicairos, Nidia M.Editorial
Elsevier
Materia
Aspergillosis Aspergillosis COVID-19 COVID-19 Invasive fungal infections Invasive fungal infections
Fecha
2024-02Referencia bibliográfica
Publisher version: Urias-Barreras, C. M.; Rodríguez Archilla, A.; Canizalez-Roman, A. [et al.]. (2024). Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series. Journal of Stomatology, Oral and Maxillofacial Surgery Volume 125, Issue 1, February 2024, 101615. https://doi.org/10.1016/j.jormas.2023.101615
Resumen
Background: Fungal infections, during or as a consequence of SARS-CoV-2 infection, associated with uncontrolled diabetes mellitus and indiscriminate use of corticosteroids have been reported. In the jaw, mostly mucormycosis has been diagnosed in hospitals.
Methods: A retrospective, cross-sectional, descriptive study of the clinical, imaging, and histopathologic characteristics of maxillary invasive fungal infection in post-COVID-19 patients diagnosed in a private non-hospital oral pathology service in Mexico during 2020-2022 was conducted.
Results: We found 20 cases of maxillary invasive fungal infections in post-COVID-19 patients, 75% including a diagnosis of mucormycosis and 25% diagnosed as probable aspergillosis. The most common signs and symptoms were exposed necrotic bone followed by tooth mobility, discharge, and pain. On imaging, unilateral maxillary sinus involvement was observed in 6 cases (30%), and bilateral maxillary sinus involvement was observed in 3 cases (15%).
Conclusions: It is essential to consider the association of osteonecrosis of the jaw in post-COVID-19 patients, with aspergillosis, not only mucormycosis, for early diagnosis and appropriate treatment. Background: Fungal infections, during or as a consequence of SARS-CoV-2 infection, associated with uncontrolled diabetes mellitus and indiscriminate use of corticosteroids have been reported. In the jaw, mostly mucormycosis has been diagnosed in hospitals.
Methods: A retrospective, cross-sectional, descriptive study of the clinical, imaging, and histopathologic characteristics of maxillary invasive fungal infection in post-COVID-19 patients diagnosed in a private non-hospital oral pathology service in Mexico during 2020-2022 was conducted.
Results: We found 20 cases of maxillary invasive fungal infections in post-COVID-19 patients, 75% including a diagnosis of mucormycosis and 25% diagnosed as probable aspergillosis. The most common signs and symptoms were exposed necrotic bone followed by tooth mobility, discharge, and pain. On imaging, unilateral maxillary sinus involvement was observed in 6 cases (30%), and bilateral maxillary sinus involvement was observed in 3 cases (15%).
Conclusions: It is essential to consider the association of osteonecrosis of the jaw in post-COVID-19 patients, with aspergillosis, not only mucormycosis, for early diagnosis and appropriate treatment.





